Human Insulin Market Research Report - Forecast till 2030

Human Insulin Market: Information by Type (Traditional Human Insulin (Premixed Traditional, Intermediate Acting and Short-Acting), Modern Human Insulin (Premixed Modern, Long-Acting and Rapid Acting) and Brand (Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin and Insuman)) - Forecast till 2030

ID: MRFR/Pharma/0445-CR | February, 2021 | Region : Global

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

6 Human Insulin Market, by Type

6.1 Introduction

6.2 Traditional Human Insulin

6.2.1 Premixed Traditional

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2 Intermediate Acting

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.3 Short Acting

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Modern Human Insulin

6.3.1 Premixed Modern

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2 Long Acting

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3 Rapid Acting

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7 Human Insulin Market, by Brand

7.1 Introduction

7.2 Lantus

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Novorapid

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Humalog

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Novomix

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 Levemir

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7 Apidar

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.8 Humulin

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.9 Insuman

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8 Global Human Insulin Market, by Region

8.1 Introduction

8.2 Americas

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.1 North America

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.1.1 US

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.1.2 Canada

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.2.2 South America

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3 Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1 Western Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.1 Germany

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.2 France

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.3 Italy

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.4 Spain

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.5 UK

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.1.6 Rest of Western Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.3.2 Eastern Europe

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4 Asia-Pacific

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.1 Japan

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.2 China

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.3 India

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.4 Australia

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.5 South Korea

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.4.6 Rest of Asia-Pacific

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.5 Middle East & Africa

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.5.1 Middle East

Human Insulin Market, by Type

Human Insulin Market, by Brand

8.5.2 Africa

Human Insulin Market, by Type

Human Insulin Market, by Brand

9 Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

10 Company Profiles

10.1 ADOCIA

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 MERCK & CO., INC.

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Julphar

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Pfizer Inc.

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Bristol-Myers Squibb Company

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 GLAXOSMITHKLINE PLC

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 SANOFI

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Oramed

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Novo Nordisk India Pvt. Ltd

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Eli Lilly and Company

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 BIOCON

10.11.1 Overview

10.11.2 Product Overview

10.11.3 Financials

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.12 Tonghua Dongbao Pharmaceutical Co., Ltd

10.12.1 Overview

10.12.2 Product Overview

10.12.3 Financials

10.12.4 Key Developments

10.12.5 SWOT Analysis

10.13 Others

11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the global Human Insulin market

12 Appendix

13 LIST OF TABLES

Table 1 Human Insulin Market Synopsis, 2020–2027

Table 2 Human Insulin Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Human Insulin Market, by Region, 2020–2027 (USD Million)

Table 4 Global Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 5 Global Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 6 North America: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 7 North America: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 8 US: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 9 US: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 10 Canada: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 11 Canada: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 12 South America: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 13 South America: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 14 Europe: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 15 Europe: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 16 Western Europe: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 17 Western Europe: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 18 Eastern Europe: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 19 Eastern Europe: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 20 Asia-Pacific: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 21 Asia-Pacific: Human Insulin Market, by Brand, 2020–2027 (USD Million)

Table 22 Middle East & Africa: Human Insulin Market, by Type, 2020–2027 (USD Million)

Table 23 Middle East & Africa: Human Insulin Market, by Brand, 2020–2027 (USD Million)

14 LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Human Insulin Market

Figure 3 Market Dynamics for Global Human Insulin Market

Figure 4 Human Insulin Market Share, by Type, 2020

Figure 5 Human Insulin Market Share, by Brand, 2020

Figure 6 Human Insulin Market Share, by Region, 2020

Figure 7 North America: Human Insulin Market Share, by Country, 2020

Figure 8 Europe: Human Insulin Market Share, by Country, 2020

Figure 9 Asia-Pacific: Human Insulin Market Share, by Country, 2020

Figure 10 Middle East & Africa: Human Insulin Market Share, by Region, 2020

Figure 11 Human Insulin Market: Company Share Analysis, 2020 (%)

Figure 12 ADOCIA: Key Financials

Figure 13 ADOCIA: Segmental Revenue

Figure 14 ADOCIA: Geographical Revenue

Figure 15 MERCK & CO., INC.: Key Financials

Figure 16 MERCK & CO., INC.: Segmental Revenue

Figure 17 MERCK & CO., INC.: Geographical Revenue

Figure 18 Julphar: Key Financials

Figure 19 Julphar: Segmental Revenue

Figure 20 Julphar: Geographical Revenue

Figure 21 Pfizer Inc.: Key Financials

Figure 22 Pfizer Inc.: Segmental Revenue

Figure 23 Pfizer Inc.: Geographical Revenue

Figure 24 Bristol-Myers Squibb Company: Key Financials

Figure 25 Bristol-Myers Squibb Company: Segmental Revenue

Figure 26 Bristol-Myers Squibb Company: Geographical Revenue

Figure 27 GLAXOSMITHKLINE PLC: Key Financials

Figure 28 GLAXOSMITHKLINE PLC: Segmental Revenue

Figure 29 GLAXOSMITHKLINE PLC: Geographical Revenue

Figure 30 Oramed: Key Financials

Figure 31 Oramed: Segmental Revenue

Figure 32 Oramed: Geographical Revenue

Figure 33 Novo Nordisk India Pvt Ltd: Key Financials

Figure 34 Novo Nordisk India Pvt Ltd: Segmental Revenue

Figure 35 Novo Nordisk India Pvt Ltd: Geographical Revenue

Figure 36 Eli Lilly and Company: Key Financials

Figure 37 Eli Lilly and Company: Segmental Revenue

Figure 38 Eli Lilly and Company: Geographical Revenue

Figure 39 SANOFI: Key Financials

Figure 40 SANOFI: Segmental Revenue

Figure 41 SANOFI: Geographical Revenue

Figure 42 BIOCON: Key Financials

Figure 43 BIOCON: Segmental Revenue

Figure 44 BIOCON: Geographical Revenue

Figure 45 Tonghua Dongbao Pharmaceutical Co., Ltd.: Key Financials

Figure 46 Tonghua Dongbao Pharmaceutical Co., Ltd.: Segmental Revenue

Figure 47 Tonghua Dongbao Pharmaceutical Co., Ltd.: Geographical Revenue

Human Insulin Market